Taro Pharmaceutical Industries Ltd. (TARO)
NYSE: TARO · IEX Real-Time Price · USD
42.21
-0.02 (-0.05%)
Apr 24, 2024, 3:36 PM EDT - Market open

TARO Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019201820172016201520142013 2012 - 2003
Revenue
572.95561.35548.97644.77669.89661.91879.39950.75862.94759.29
Upgrade
Revenue Growth (YoY)
2.07%2.25%-14.86%-3.75%1.21%-24.73%-7.51%10.18%13.65%13.16%
Upgrade
Cost of Revenue
304.63268.23252.31245.04224.17198.41208.14171.79186.36179.28
Upgrade
Gross Profit
268.32293.12296.66399.73445.72463.51671.25778.97676.59580.01
Upgrade
Selling, General & Admin
198.37113.6891.3693.4189.9788.285.6692.3787.6491.73
Upgrade
Research & Development
52.2454.5460.1559.7863.2470.4270.6471.1665.5155.43
Upgrade
Other Operating Expenses
-2.4657.22556.03-3.02-5.49-0.01-11.21-1.71-6.941.22
Upgrade
Operating Expenses
248.15225.44707.54150.17147.72158.61145.09161.82146.22148.38
Upgrade
Operating Income
20.1867.69-410.88249.55298304.9526.16617.15530.37431.62
Upgrade
Interest Expense / Income
-18.04-10.17-19.81-48.48-58.8512.53-34.64-19.67-51.31-12.29
Upgrade
Other Expense / Income
---14.090.310.35-0.740.660.581.360.79
Upgrade
Pretax Income
38.2177.86-376.99297.73356.51293.1560.14636.25580.32443.12
Upgrade
Income Tax
12.7719.599.6753.4974.7381.95103.7895.3196.0682.73
Upgrade
Net Income
25.4558.27-386.65244.24281.78211.15456.36540.93484.26360.39
Upgrade
Net Income Growth
-56.33%---13.32%33.45%-53.73%-15.64%11.70%34.37%35.38%
Upgrade
Shares Outstanding (Basic)
38383838394041434344
Upgrade
Shares Outstanding (Diluted)
38383838394041434344
Upgrade
Shares Change
-0.15%-1.49%-0.65%-1.36%-2.90%-2.77%-3.57%-0.00%-3.26%-0.98%
Upgrade
EPS (Basic)
0.681.55-10.126.357.235.2611.0512.6211.318.14
Upgrade
EPS (Diluted)
0.681.55-10.126.357.235.2611.0512.6211.318.14
Upgrade
EPS Growth
-56.13%---12.17%37.45%-52.40%-12.44%11.58%38.94%36.81%
Upgrade
Free Cash Flow
14.17-170.528.78244.97296.69297.88410.29376.16387.01336.4
Upgrade
Free Cash Flow Per Share
0.38-4.530.756.377.617.429.938.789.047.60
Upgrade
Dividend Per Share
----12.810-----
Upgrade
Gross Margin
46.83%52.22%54.04%62.00%66.54%70.03%76.33%81.93%78.40%76.39%
Upgrade
Operating Margin
3.52%12.06%-74.85%38.70%44.49%46.06%59.83%64.91%61.46%56.85%
Upgrade
Profit Margin
4.44%10.38%-70.43%37.88%42.06%31.90%51.89%56.90%56.12%47.46%
Upgrade
Free Cash Flow Margin
2.47%-30.37%5.24%37.99%44.29%45.00%46.66%39.56%44.85%44.31%
Upgrade
Effective Tax Rate
33.41%25.16%-17.96%20.96%27.96%18.53%14.98%16.55%18.67%
Upgrade
EBITDA
52.393.6-373.12270.63316.26322.13540.33631.42544.8447.4
Upgrade
EBITDA Margin
9.13%16.67%-67.97%41.97%47.21%48.67%61.44%66.41%63.13%58.92%
Upgrade
Depreciation & Amortization
32.1325.9223.6821.3818.616.514.8314.8515.816.57
Upgrade
EBIT
20.1867.69-396.8249.24297.66305.64525.5616.57529.01430.83
Upgrade
EBIT Margin
3.52%12.06%-72.28%38.66%44.43%46.17%59.76%64.85%61.30%56.74%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).